drugset / Trial / NCT01391273

Safety and Efficacy Study of Bimatoprost in Japanese Patients With Eyelash Hypotrichosis

NCT01391273

Phase 3 Completed 173 enrolled Allergan
RandomizedParallel-groupTriple-blindTreatment

Summary

This study will evaluate the safety and efficacy of bimatoprost solution 0.03% compared with vehicle in Japanese adults with hypotrichosis of the eyelashes.

Timeline

Start
2011-07-01
Primary completion
2012-05-19
Completion
2012-05-19

Drugs

EvaluationDrugModalityDoseRoute
Subject Bimatoprost Other / unclassified 0.03 % Topical